Hem › B-cellsleukemi › Texas
Kliniska studier för B-cellsleukemi i Texas
12 studier för B-cellsleukemi söker deltagare vid platser i Texas.
Städer i Texas
Officiell studietext (engelska)
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, Houston
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT06542250Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT04728893Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
- Texas Children's Hospital, Houston
- The Methodist Hospital, Houston
RekryterarFas 1
Upp till ålder 75 · Alla kön · Uppdaterad 16 sep. 2026 · NCT06345027A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Research Site, Houston
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06564038Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Houston
RekryterarFas 3
Ålder 18 till 18 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07509151Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
- Texas Children's Hospital, Houston
RekryterarFas 1
12 Months – 25 Years · Alla kön · Uppdaterad 4 sep. 2026 · NCT05010564Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- University of Texas, Southwestern, Dallas
- Baylor Texas Children's Hospital, Houston
RekryterarFas 2
Ålder 7 till 25 · Alla kön · Uppdaterad 19 aug. 2026 · NCT05082519A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Lumi Research, Kingwood
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT05254743A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
- UT Southwestern Medical Center, Dallas
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 31 juli 2026 · NCT06708897The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
RekryterarFas 1/2
Ålder 12 till 95 · Alla kön · Uppdaterad 15 apr. 2026 · NCT04329728A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- MD Anderson, Houston
RekryterarFas 2
Ålder 18 till 66 · Alla kön · Uppdaterad 17 mars 2026 · NCT06859424Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Ut Southwestern, Dallas
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 22 jan. 2026 · NCT06357754Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.